Dr Reddy’s launches Remdesivir under a brand name 'Redyx' for Covid-19 treatment

09-09-2020 Wed 16:09

Dr Reddy's Laboratories on Wednesday announced the launch of Remdesivir, meant for treatment of Covid-19 patients, under a brand name ‘Redyx’ in India. According to a press release from the drug maker, the launch is part of the licensing agreement with Gilead Sciences, Inc (Gilead) that grants Dr Reddys the right to register, manufacture and sell Remdesivir, a potential treatment for Covid-19, in 127 countries including India. Remdesivir is approved by Drug Controller General of India (DCGI) for restricted emergency use in India for the treatment of Covid-19 patients hospitalised with severe symptoms.

Advertisement 2

More Video News
Thumb
Thumb
Thumb
Thumb
Thumb
Advertisement 3
Thumb
Thumb
Thumb
Thumb
Thumb
Thumb
Thumb
Thumb
Thumb
Thumb
..more
Advertisement 4